Drug trial targets rare joint tumors when surgery Isn't an option
NCT ID NCT04703322
Summary
This study is testing a drug called pexidartinib in Japanese adults with tenosynovial giant cell tumor (TGCT), a rare, non-cancerous joint tumor. The goal is to see if the drug is safe, how the body processes it, and if it can shrink tumors in people for whom surgery isn't a good option. Researchers will measure tumor size, joint movement, pain, and physical function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kanazawa University Hospital
Ishikawa, 920-8641, Japan
-
Kyushu University Hospital
Fukuoka, 812-8582, Japan
-
Nagoya University Hospital
Aichi, 466-8560, Japan
-
National Cancer Center Hospital
Tokyo, 104-0045, Japan
-
National Hospital Organization Osaka National Hospital
Osaka, 540-0006, Japan
-
Osaka International Cancer Institute
Osaka, 541-8567, Japan
Conditions
Explore the condition pages connected to this study.